TITLE:
Phenotypic Characterization of Carbapenemase-Producing Enterobacteriaceae Strains in a Referral Teaching Hospital in Yaoundé, Cameroon
AUTHORS:
Cecile Ingrid Djuikoue, Paule Dana Djouela Djoulako, Rodrigue Kamga Wouambo, Charlène Nkouankou Tomi, Christiane Possi Kiyang, Murielle Chantale Tchitchoua, Vynnie Manuella Nyatchoutou, Blondelle Kitio Messeu, Herman Koyouo Tagne, Cedric Dylan Seugnou Nana, Nadjia Benhamed, Hortense Gonsu Kamga, Benjamin D. Thumamo Pokam
KEYWORDS:
Enterobacteriaceae, Antibiotics, Carbapenemase, Resistance
JOURNAL NAME:
Open Journal of Medical Microbiology,
Vol.13 No.1,
March
7,
2023
ABSTRACT: Background: Carbapenemase-producing
Enterobacteriaceae (CPE) are an important and increasing threat to global
health. They are nowadays more encountered routinely in hospitals and cause
high morbidity and mortality due to limited therapeutic alternatives. This
study sought to determine the prevalence of CPE in Yaoundé teaching hospital,
Cameroon, and the associated risk factors. Materials and Method: To achieve this goal, a descriptive cross-sectional study coupled to an
analytical component with consecutive collection of Enterobacteria strains was carried out during a three-month
period (from 27th July to 24th October 2018) in the University Teaching
Hospital of Yaoundé,
Cameroon. The oxidase and biochemical identification tests using a miniaturized Api 20 E system were performed on colonies grown on Eosin
Methylene Blue (EMB) medium and subcultured on nutrient agar. Drug
susceptibility testing was carried out according to the Antibiogram Committee of the French Society of Microbiology (CA-SFM
2018.V.2.0). The detection of carbapenemase production was performed by the CA-SFM 2018 algorithm for the screening of carbapenemase-producing
enterobacteriaceae and its classification by inhibitory synergy tests. Results: Out of the 104 isolates, Escherichia coli (50%) was the most prevalent species, followed by Klebsiella pneumoniae (37.5%) and Citrobacter frendii (12.5%). Drugs susceptibility patterns showed a
high resistance to penicillins group (97.4% to amoxicillin), cephalosporins
(68.4% to cefotaxim, 58.1% to cefixim, 60.7% to ceftazidim, 57.1% of cefoxitin) and aztreonam (55.7%). However, 11.9%
carbapenems related resistance was noticed: 14.4% to imipenem, 13.8% to
ertapenem and 7.5% to meropenem. Numerous co-resistance to quinolones (65.8%), fluoroquinolones (49.6%), aminoglycosides (49.6%) and cotrimoxazole (71.8%)
were also observed. From 104 isolates, AmpC production represented 23.08%
(25/104) and 36.54% (38/104) were ESBL-isolates. The overall prevalence of CPE
was 25% (26/104) with K.pneumoniae predominant
(61.53%). Besides, Class A and class B carbapenemase were mainly produced with respectively 20% (21/104) and 5% (5/104).
Univariate analysis revealed a significant association of carbapenemase production
to Klebsiella pneumoniae (p = 0.01),
ESBL and AmpC production ((P = 0.01 and P = 0.001 respectively) while that
association was only significant to Klebsiella
spp (p = 0.04) and AmpC production (p = 0.02) in multivariate analysis. Conclusion: The multi-resistance of Enterobacteriaceae to antibiotics in Cameroon has considerably increased. More attention
should be paid to those bacteria to stall antimicrobial resistance spread.